Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Prime Medicine Inc
(NQ:
PRME
)
3.450
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Prime Medicine Inc
< Previous
1
2
3
4
Next >
2 Magnificent Growth Stocks With Room to Run
March 27, 2024
These deeply undervalued growth stocks could be big winners for patient shareholders.
Via
The Motley Fool
Short-Squeeze Roulette: 3 Stocks That Could Leave Bears Begging
March 14, 2024
Explore short-squeeze stocks for potential surges, spotlighting investor strategies and trends that could benefit your portfolio.
Via
InvestorPlace
Cathie Wood Just Bought These 3 Biotech Stocks. Should You Buy, Too?
March 01, 2024
On the leading edge of rare disease treatment and therapy is where you will find these Cathie Wood biotech stocks.
Via
InvestorPlace
Recap: Prime Medicine Q4 Earnings
March 01, 2024
Via
Benzinga
Prime Medicine Reports Full Year 2023 Financial Results and Provides Business Updates
March 01, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Prime Medicine to Participate in Upcoming Investor Conferences
February 28, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Prime Medicine Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
February 20, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Prime Medicine Announces Pricing of Upsized Public Offering
February 14, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Prime Medicine Announces Proposed Public Offering of Common Stock
February 14, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Prime Medicine to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
February 01, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Prime Medicine Receives Up to $15 Million from Cystic Fibrosis Foundation to Advance Hotspot and PASSIGE™ Prime Editors for Cystic Fibrosis
January 25, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
2 gene editing stocks to keep on your 2024 watchlist
January 23, 2024
Gene therapy is receiving much of the spotlight in the medical sector in 2024. The FDA approval for Casgevy, Vertex Pharmaceuticals Inc. (NASDAQ: VRTX)
Via
MarketBeat
Exposures
Product Safety
Morgan Stanley Reports Q4 Results, Joins Boeing, Alcoa And Other Big Stocks Moving Lower On Tuesday
January 16, 2024
U.S. stocks traded lower, with the Dow Jones index falling more than 250 points on Tuesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Prime Medicine Appoints Allan Reine, M.D., as Chief Financial Officer
January 05, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Prime Medicine to Present at 42nd Annual J.P. Morgan Healthcare Conference
January 02, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
December 22, 2023
Shares of AAR Corp. (NYSE: AIR) fell during Friday’s session after the company reported mixed second-quarter financial results.
Via
Benzinga
Better Growth Stock: Archer Aviation or Prime Medicine?
December 19, 2023
Which of these innovation-themed growth stocks is the better buy?
Via
The Motley Fool
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead.
December 04, 2023
The gene-editing revolution is unfolding at a record pace. Still, risks abound, and picking individual stocks may not be the wisest approach.
Via
The Motley Fool
1 Cathie Wood Stock That Could Deliver Life-Changing Returns in 10 Years
November 30, 2023
This gene-editing company could sport a best-in-class platform.
Via
The Motley Fool
Prime Medicine to Present at Upcoming Investor Conferences
November 08, 2023
From
Prime Medicine, Inc.
Via
GlobeNewswire
Ryanair Holdings, Prime Medicine And Other Big Stocks Moving Higher In Monday's Pre-Market Session
November 06, 2023
U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
Why Bluegreen Vacations Shares Are Trading Higher By Around 105%? Here Are Other Stocks Moving In Monday's Mid-Day Session
November 06, 2023
Gainers Carbon Revolution Public Limited (NASDAQ: CREV) shares jumped 396.2% to $145.49 after gaining 100% on Friday. The company’s stock began trading on Friday following merger with Twin Ridge...
Via
Benzinga
DISH Network, Goodyear And 3 Stocks To Watch Heading Into Monday
November 06, 2023
With U.S. stock futures trading slightly higher this morning on Monday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Prime Medicine Reports Third Quarter 2023 Financial Results and Provides Business Updates
November 03, 2023
From
Prime Medicine, Inc.
Via
GlobeNewswire
Prime Medicine Presents First-ever Prime Editing Data in Non-human Primates Demonstrating Highly Efficient Ability of Prime Editors to Precisely Correct Disease-causing Mutation of GSD1b
October 27, 2023
From
Prime Medicine, Inc.
Via
GlobeNewswire
Prime Medicine Presents First In Vivo Proof-of-Concept Prime Editing Data Demonstrating Ability of Prime Editors to Treat Ophthalmological Diseases
October 24, 2023
From
Prime Medicine, Inc.
Via
GlobeNewswire
7 Biotech Stocks to Get In Now Before Investors Catch On
October 23, 2023
Biotech stocks are down, but there are hidden gems among the rubble. Get in now before the broader market finds them.
Via
InvestorPlace
Prime Medicine to Highlight Positive Preclinical Developments Across Prime Editing Pipeline and Platform at Upcoming Industry Conferences
October 17, 2023
From
Prime Medicine, Inc.
Via
GlobeNewswire
Preclinical-Phase Firm Prime Medicine's Gene Editing Platform Has Potential: Analyst
October 09, 2023
BMO Capital Markets has initiated coverage on Prime Medicine Inc (NASDAQ: PRME), a preclinical-stage company focused on developing therapies based on prime editing.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 9, 2023
October 09, 2023
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.